Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The future of translational research on alcohol use disorder
Lara A. Ray, Erica N. Grodin, Lorenzo Leggio, et al.
Addiction Biology (2020) Vol. 26, Iss. 2
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

The etiologic, theory-based, ontogenetic hierarchical framework of alcohol use disorder: A translational systematic review of reviews.
Cassandra L. Boness, Ashley L. Watts, Kimberly N. Moeller, et al.
Psychological Bulletin (2021) Vol. 147, Iss. 10, pp. 1075-1123
Open Access | Times Cited: 57
Immune treatments for alcohol use disorder: A translational framework
Lindsay R. Meredith, Elizabeth M. Burnette, Erica N. Grodin, et al.
Brain Behavior and Immunity (2021) Vol. 97, pp. 349-364
Open Access | Times Cited: 41
Translational opportunities in animal and human models to study alcohol use disorder
Steven J. Nieto, Erica N. Grodin, Claudia G. Aguirre, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 35
Criterion validity of the genetic addiction risk severity (GARS) as a marker of reward deficiency in polydrug addiction: a multi-center study
Kenneth Blum, Brett C. Haberstick, Andrew Smolen, et al.
Journal of Translational Genetics and Genomics (2025) Vol. 9, Iss. 2, pp. 76-100
Open Access
The Association Between Impulsivity and Relapse in Patients With Alcohol Use Disorder: A Literature Review
Wilco Sliedrecht, Hendrik G. Roozen, Katie Witkiewitz, et al.
Alcohol and Alcoholism (2020) Vol. 56, Iss. 6, pp. 637-650
Open Access | Times Cited: 37
Efficacy of Combining Varenicline and Naltrexone for Smoking Cessation and Drinking Reduction: A Randomized Clinical Trial
Lara A. Ray, ReJoyce Green, Craig K. Enders, et al.
American Journal of Psychiatry (2021) Vol. 178, Iss. 9, pp. 818-828
Open Access | Times Cited: 29
Endpoints for Pharmacotherapy Trials for Alcohol Use Disorder
Malia A. Belnap, Kaitlin R. McManus, Erica N. Grodin, et al.
Pharmaceutical Medicine (2024) Vol. 38, Iss. 4, pp. 291-302
Open Access | Times Cited: 4
Differential association between the GLP1R gene variants and brain functional connectivity according to the severity of alcohol use
Mehdi Farokhnia, Samantha J. Fede, Erica N. Grodin, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 16
Structured tracking of alcohol reinforcement (STAR) for basic and translational alcohol research
Alex Brown, Hannah E. Branthwaite, Zahra Z. Farahbakhsh, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 4, pp. 1585-1598
Open Access | Times Cited: 10
Targeting muscarinic receptors for the treatment of alcohol use disorders: opportunities and hurdles for clinical development
Leigh C. Walker, Kade L. Huckstep, Howard C. Becker, et al.
British Journal of Pharmacology (2023) Vol. 181, Iss. 22, pp. 4385-4398
Open Access | Times Cited: 8
Reward drinking and naltrexone treatment response among young adult heavy drinkers
Corey R. Roos, Krysten W. Bold, Katie Witkiewitz, et al.
Addiction (2021) Vol. 116, Iss. 9, pp. 2360-2371
Open Access | Times Cited: 19
Optogenetic inhibition of light‐captured alcohol‐taking striatal engrams facilitates extinction and suppresses reinstatement
Valerie Vierkant, Xueyi Xie, Zhenbo Huang, et al.
Alcohol Clinical and Experimental Research (2024) Vol. 48, Iss. 9, pp. 1728-1739
Open Access | Times Cited: 2
Clinical Neuroscience of Addiction: What Clinical Psychologists Need to Know and Why
Lara A. Ray, Erica N. Grodin
Annual Review of Clinical Psychology (2021) Vol. 17, Iss. 1, pp. 465-493
Closed Access | Times Cited: 16
The Promise of an Evolutionary Perspective of Alcohol Consumption
Benjamin L Clites, Hans A. Hofmann, Jonathan T. Pierce
Neuroscience Insights (2023) Vol. 18
Open Access | Times Cited: 6
Glucocorticoid receptors regulate central amygdala GABAergic synapses in Marchigian-Sardinian alcohol-preferring rats
Sophia Khom, Vittoria Borgonetti, Valentina Vozella, et al.
Neurobiology of Stress (2023) Vol. 25, pp. 100547-100547
Open Access | Times Cited: 6
Drinking reduction during cognitive behavioral therapy for alcohol use disorder is associated with a reduction in anterior insula‐bed nucleus of the stria terminalis resting‐state functional connectivity
A. Benjamin Srivastava, Juan Sanchez‐Peña, Frances R. Levin, et al.
Alcoholism Clinical and Experimental Research (2021) Vol. 45, Iss. 8, pp. 1596-1606
Open Access | Times Cited: 15
Cannabinoids for the treatment of cannabis use disorder: New avenues for reaching and helping youth?
Kristine Rømer Thomsen, Birgitte Thylstrup, Emily A. Kenyon, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 132, pp. 169-180
Open Access | Times Cited: 13
Association Between Fatty Acid Amide Hydrolase and Alcohol Response Phenotypes: A Positron Emission Tomography Imaging Study With [11C]CURB in Heavy-Drinking Youth
Laura M. Best, Christian S. Hendershot, Jennifer F. Buckman, et al.
Biological Psychiatry (2022) Vol. 94, Iss. 5, pp. 405-415
Closed Access | Times Cited: 9
Development of an accelerometer‐based wearable sensor approach for alcohol consumption detection
Nicholas J. Bush, Adriana K. Cushnie, Madison Sinclair, et al.
Alcohol Clinical and Experimental Research (2024) Vol. 48, Iss. 12, pp. 2341-2351
Open Access | Times Cited: 1
Neural correlates of the addictions neuroclinical assessment (ANA) incentive salience factor among individuals with alcohol use disorder
Steven J. Nieto, Erica N. Grodin, Lara A. Ray
Behavioural Brain Research (2024) Vol. 464, pp. 114926-114926
Open Access | Times Cited: 1
Medication Development For Aud: A Systematic Review Of Clinical Trial Methodology
Stefano Di Donato, Lindsay R. Meredith, Steven J. Nieto, et al.
Alcohol (2024) Vol. 120, pp. 194-203
Closed Access | Times Cited: 1
Validation of predicted individual treatment effects in out of sample respondents
Alena Kuhlemeier, Thomas Jaki, Katie Witkiewitz, et al.
Statistics in Medicine (2024) Vol. 43, Iss. 22, pp. 4349-4360
Closed Access | Times Cited: 1
Time for a paradigm shift: The adolescent brain in addiction treatment
Kristen L. Mackiewicz Seghete, Francesca M. Filbey, Karen A. Hudson, et al.
NeuroImage Clinical (2022) Vol. 34, pp. 102960-102960
Open Access | Times Cited: 6
Translational models of addiction phenotypes to advance addiction pharmacotherapy
Lara A. Ray, Steven J. Nieto, Erica N. Grodin
Annals of the New York Academy of Sciences (2022) Vol. 1519, Iss. 1, pp. 118-128
Open Access | Times Cited: 6
A Critical Review of Alcohol Administration Guidelines in Laboratory Medication Screening Research: Is It Time to Include Treatment Seekers?
Walter Roberts, Terril L. Verplaetse, Vijay A. Ramchandani, et al.
Alcoholism Clinical and Experimental Research (2020) Vol. 45, Iss. 1, pp. 15-24
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top